Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SOUMEN KHATUA and STEVEN I SHERMAN.
SOUMEN KHATUA
Connection Strength
0.040
STEVEN I SHERMAN
  1. Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated Malignancies. JCO Precis Oncol. 2018; 2.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.